Viridian Therapeutics appoints Kristian Humer as CFO and CBO, effective July 26, 2021

Viridian Therapeutics, Inc.\DE

Mr. Humer will receive an annual base salary of $530,000, a sign-on bonus of $400,000, and a target bonus of 45% of base salary.
He received an initial equity grant of options to purchase 360,000 shares, vesting over four years.
Mr. Humer previously served as Managing Director in the Global Healthcare team at Citigroup Inc.
The inducement grant was approved by a majority of independent directors in accordance with Nasdaq Listing Rule 5635(c)(4).

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kristian Humer

Chief Financial Officer and Chief Business Officer

VRDN · Viridian Therapeutics, Inc.\DE

Effective: 2021-07-26
Filed: July 26, 2021, 7:59 PM ET

On July 26, 2021, Viridian Therapeutics, Inc. (the “Company”) announced the appointment of Kristian Humer as the Company’s Chief Financial Officer and Chief Business Officer, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kristian Humer was appointed as Chief Financial Officer and Chief Business Officer at Viridian Therapeutics, Inc.\DE.

Action: appointed
Role: Chief Financial Officer and Chief Business Officer

Exact text from the filing

On July 26, 2021, Viridian Therapeutics, Inc. (the “Company”) announced the appointment of Kristian Humer as the Company’s Chief Financial Officer and Chief Business Officer, effective immediately.

View on SEC.gov

Viridian Therapeutics, Inc.\DE filing history →

Source: SEC EDGAR

accession 0001193125-21-223656

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.